Literature DB >> 20357090

Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.

Ruy M Ribeiro1, Li Qin, Leslie L Chavez, Dongfeng Li, Steven G Self, Alan S Perelson.   

Abstract

During primary infection, the number of HIV-1 particles in plasma increases rapidly, reaches a peak, and then declines until it reaches a set point level. Understanding the kinetics of primary infection, and its effect on the establishment of chronic infection, is important in defining the early pathogenesis of HIV. We studied the viral dynamics of very early HIV-1 infection in 47 subjects identified through plasma donation screening. We calculated how fast the viral load increases and how variable this parameter is among individuals. We also estimated the basic reproductive ratio, the number of new infected cells generated by an infectious cell at the start of infection when target cells are not limiting. The initial viral doubling time had a median of 0.65 days with an interquartile range of 0.56 to 0.91 days. The median basic reproductive ratio was 8.0 with an interquartile range of 4.9 to 11. In 15 patients, we also observed the postpeak decay of plasma virus and found that the virus decay occurred at a median rate of 0.60 day(-1), corresponding to a half-life of 1.2 days. The median peak viral load was 5.8 log(10) HIV-1 RNA copies/ml, and it was reached 14 days after the virus was quantifiable with an assay, with a lower limit of detection of 50 copies/ml. These results characterize the early plasma viral dynamics in acute HIV infection better than it has been possible thus far. They also better define the challenge that the immune response (or therapeutic intervention) has to overcome to defeat HIV at this early stage.

Entities:  

Mesh:

Year:  2010        PMID: 20357090      PMCID: PMC2876646          DOI: 10.1128/JVI.00127-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Mathematical analysis of delay differential equation models of HIV-1 infection.

Authors:  Patrick W Nelson; Alan S Perelson
Journal:  Math Biosci       Date:  2002 Jul-Aug       Impact factor: 2.144

Review 2.  The HIV-1 vaccine race.

Authors:  David D Ho; Yaoxing Huang
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.

Authors:  B Ramratnam; S Bonhoeffer; J Binley; A Hurley; L Zhang; J E Mittler; M Markowitz; J P Moore; A S Perelson; D D Ho
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

4.  Modeling plasma virus concentration during primary HIV infection.

Authors:  M A Stafford; L Corey; Y Cao; E S Daar; D D Ho; A S Perelson
Journal:  J Theor Biol       Date:  2000-04-07       Impact factor: 2.691

5.  A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.

Authors:  Martin Markowitz; Michael Louie; Arlene Hurley; Eugene Sun; Michele Di Mascio; Alan S Perelson; David D Ho
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Mixed models for longitudinal left-censored repeated measures.

Authors:  Rodolphe Thiébaut; Hélène Jacqmin-Gadda
Journal:  Comput Methods Programs Biomed       Date:  2004-06       Impact factor: 5.428

7.  Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy.

Authors:  Narendra M Dixit; Martin Markowitz; David D Ho; Alan S Perelson
Journal:  Antivir Ther       Date:  2004-04

8.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

9.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

10.  Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.

Authors:  Thomas B Campbell; Kristina Schneider; Terri Wrin; Christos J Petropoulos; Elizabeth Connick
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more
  110 in total

1.  Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV.

Authors:  Dominique Cadosch; Sebastian Bonhoeffer; Roger Kouyos
Journal:  J R Soc Interface       Date:  2012-03-14       Impact factor: 4.118

2.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.

Authors:  Nancie M Archin; Naveen K Vaidya; Joann D Kuruc; Abigail L Liberty; Ann Wiegand; Mary F Kearney; Myron S Cohen; John M Coffin; Ronald J Bosch; Cynthia L Gay; Joseph J Eron; David M Margolis; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  SPMM: estimating infection duration of multivariant HIV-1 infections.

Authors:  Tanzy M T Love; Sung Yong Park; Elena E Giorgi; Wendy J Mack; Alan S Perelson; Ha Youn Lee
Journal:  Bioinformatics       Date:  2015-12-31       Impact factor: 6.937

4.  Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.

Authors:  Daniel B Reeves; Christopher W Peterson; Hans-Peter Kiem; Joshua T Schiffer
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

5.  Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.

Authors:  Vitaly V Ganusov; Nilu Goonetilleke; Michael K P Liu; Guido Ferrari; George M Shaw; Andrew J McMichael; Persephone Borrow; Bette T Korber; Alan S Perelson
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV Infection.

Authors:  Victor Garcia; Marcus W Feldman
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

7.  Modeling brain lentiviral infections during antiretroviral therapy in AIDS.

Authors:  Weston C Roda; Michael Y Li; Michael S Akinwumi; Eugene L Asahchop; Benjamin B Gelman; Kenneth W Witwer; Christopher Power
Journal:  J Neurovirol       Date:  2017-05-16       Impact factor: 2.643

8.  Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.

Authors:  John Wei Lau; David N Levy; Dominik Wodarz
Journal:  J Theor Biol       Date:  2014-12-12       Impact factor: 2.691

9.  Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.

Authors:  Laurelle Jackson; Jessica Hunter; Sandile Cele; Isabella Markham Ferreira; Andrew C Young; Farina Karim; Rajhmun Madansein; Kaylesh J Dullabh; Chih-Yuan Chen; Noel J Buckels; Yashica Ganga; Khadija Khan; Mikael Boulle; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

10.  Estimating time since infection in early homogeneous HIV-1 samples using a poisson model.

Authors:  Elena E Giorgi; Bob Funkhouser; Gayathri Athreya; Alan S Perelson; Bette T Korber; Tanmoy Bhattacharya
Journal:  BMC Bioinformatics       Date:  2010-10-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.